Inactive Instrument

Highlights Seagen Inc.

Equities

SGEN

US81181C1045

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

Takeover rumors send Morphosys to high since July 2021	Feb. 05	DP
HBM Holdings Unit Nona Biosciences Signs Licensing Deal with Seagen for Tumor Medication; Shares Fall 5%	Dec. 15	MT
Pfizer Completes $43 Billion Acquisition of Seagen	Dec. 14	MT
Pfizer: Seagen acquisition now complete	Dec. 14	CF
Pfizer Inc. completed the acquisition of Seagen Inc. from Baker/Tisch Investments, L.P, a funds managed by Baker Brothers Investments and others.	Dec. 13	CI
Pfizer shares sink after it resets 2024 COVID expectations	Dec. 13	RE
Pfizer shares slide as 2024 revenue outlook underwhelms	Dec. 13	AN
Pfizer Issues 2024 Guidance Below Street View, Shares Fall	Dec. 13	MT
Pfizer Warns 2024 Revenue Could Fall, Weighed Down by Soft Demand for Covid Products	Dec. 13	DJ
Pfizer forecasts 2024 revenue below Wall Street expectations	Dec. 13	RE
Pfizer's 2024 revenue forecast below Wall Street estimate	Dec. 13	RE
Pfizer to Establish New Oncology Division Following Completion of Seagen Deal	Dec. 13	MT
Pfizer: Seagen acquisition nears completion	Dec. 12	CF
Pfizer Says Seagen Deal to Close Thursday; Commercial Operations to Be Restructured	Dec. 12	MT
Pfizer to Close $43 Billion Seagen Acquisition This Week	Dec. 12	DJ
Pfizer Says All Regulatory Approvals Received for Seagen Purchase	Dec. 12	MT
Pfizer gets OK for $43-bln Seagen deal after donating cancer drug rights	Dec. 12	RE
Pfizer says received approvals to close Seagen deal	Dec. 12	RE
Seagen Inc. Announces Phase 2 Study Evaluating the Antibody-Drug Conjugate ADCETRIS (brentuximab Vedotin) in Combination with the PD-1 Inhibitor Nivolumab and Standard Chemotherapy Agents Doxorubicin and Dacarbazine	Dec. 10	CI
Seagen Inc. Announces Data from the Phase 3 HER2CLIMB-02 Clinical Trial of TUKYSA	Dec. 06	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Seagen Inc.

Equities

SGEN

US81181C1045

Highlights

Filters